Carrhae Capital LLP lowered its position in shares of Credicorp Ltd. (NYSE:BAP – Free Report) by 73.7% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 40,669 shares of the bank’s stock after selling 113,908 shares during the period. Credicorp accounts for about 0.6% of Carrhae Capital LLP’s holdings, making the stock its 20th biggest position. Carrhae Capital LLP’s holdings in Credicorp were worth $7,455,000 at the end of the most recent reporting period.
A number of other hedge funds and other institutional investors have also bought and sold shares of the company. FMR LLC grew its position in shares of Credicorp by 6.1% during the 3rd quarter. FMR LLC now owns 3,446,621 shares of the bank’s stock valued at $623,735,000 after purchasing an additional 199,137 shares in the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC raised its position in shares of Credicorp by 782.7% in the third quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 1,326,947 shares of the bank’s stock worth $240,138,000 after buying an additional 1,176,612 shares in the last quarter. State Street Corp boosted its stake in Credicorp by 2.0% during the third quarter. State Street Corp now owns 1,123,023 shares of the bank’s stock valued at $207,235,000 after buying an additional 21,943 shares during the period. Ninety One UK Ltd grew its position in Credicorp by 4.7% during the fourth quarter. Ninety One UK Ltd now owns 1,089,334 shares of the bank’s stock worth $199,697,000 after buying an additional 49,031 shares in the last quarter. Finally, Pzena Investment Management LLC increased its stake in Credicorp by 5.2% in the 4th quarter. Pzena Investment Management LLC now owns 1,080,579 shares of the bank’s stock worth $198,092,000 after acquiring an additional 53,746 shares during the last quarter. Institutional investors own 89.81% of the company’s stock.
Credicorp Price Performance
Shares of Credicorp stock opened at $192.38 on Tuesday. The business’s 50-day moving average price is $185.19 and its 200-day moving average price is $184.91. The firm has a market capitalization of $15.30 billion, a PE ratio of 10.46, a price-to-earnings-growth ratio of 0.56 and a beta of 1.10. Credicorp Ltd. has a 12 month low of $153.27 and a 12 month high of $200.00. The company has a current ratio of 1.02, a quick ratio of 1.07 and a debt-to-equity ratio of 0.68.
Analyst Ratings Changes
Separately, Bank of America downgraded Credicorp from a “buy” rating to a “neutral” rating and dropped their price target for the company from $209.00 to $208.00 in a research report on Monday, December 16th.
Check Out Our Latest Stock Report on BAP
Credicorp Profile
Credicorp Ltd. provides various financial, insurance, and health services and products primarily in Peru and internationally. It operates through Universal Banking, Insurance and Pensions, Microfinance, and Investment Banking and Equity Management segments. The Universal Banking segment grants various credits and financial instruments to individuals and legal entities; and various deposits and current accounts.
Featured Articles
- Five stocks we like better than Credicorp
- Are Penny Stocks a Good Fit for Your Portfolio?
- Super Micro Stock: $7.2M Call Options Signal Big Upside Potential
- 3 Ways To Invest In Coffee, Other Than Drinking It
- Top 3 Buy-and-Hold Stocks for 2025: Long-Term Winners to Watch
- Canada Bond Market Holiday: How to Invest and Trade
- D-Wave Stock: Is Quantum Blockchain the Next Big Catalyst?
Want to see what other hedge funds are holding BAP? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Credicorp Ltd. (NYSE:BAP – Free Report).
Receive News & Ratings for Credicorp Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Credicorp and related companies with MarketBeat.com's FREE daily email newsletter.